ANALYSIS OF MEDICATION ADHERENCE AMONG PATIENTS TAKING DIRECT-ACTING ANTIVIRAL S FOR THE TREATMENT OF CHRONIC HEPATITIS C

被引：0
|
作者：
Margusino-Framinan, L. [1 ]
Castro-Iglesias, A. [1 ]
Mena-de-Cea, A. [1 ]
Cid-Silva, P. [1 ]
Pernas-Souto, B. [1 ]
Rodriguez-Osorio, I [1 ]
Vazquez-Rodriguez, P. [1 ]
Lopez-Calvo, S. [1 ]
Sanclaudio-Luhia, I [1 ]
Castro-Castro, J. A. [1 ]
Martin-Herranz, I [1 ]
机构：
[1] A Coruna Hosp, La Coruna, Spain
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
10.1016/j.jval.2018.04.1100
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PIN54
引用
收藏
页码：S155 / S155
页数：1
相关论文
共 50 条
  • [21] Efficacy of direct-acting antiviral treatment for chronic hepatitis C: A single hospital experience
    Kaneko, Rena
    Nakazaki, Natsuko
    Omori, Risa
    Yano, Yuichiro
    Ogawa, Masazumi
    Sato, Yuzuru
    WORLD JOURNAL OF HEPATOLOGY, 2018, 10 (01) : 88 - 94
  • [22] Prediction of hepatocellular carcinoma following direct-acting antiviral treatment for chronic hepatitis C
    Nishino, Ken
    Kawanaka, Miwa
    Tanikawa, Tomohiro
    Urata, Noriyo
    Oka, Takahito
    Nakamura, Jun
    Suehiro, Mitsuhiko
    Sasai, Takako
    Kawamoto, Hirofumi
    HEPATOLOGY, 2017, 66 : 554A - 554A
  • [23] Direct-acting antiviral treatment downregulates immune checkpoint inhibitor expression in patients with chronic hepatitis C
    Szereday, Laszlo
    Meggyes, Matyas
    Berki, Timea
    Miseta, Attila
    Farkas, Nelli
    Gervain, Judit
    Par, Alajos
    Par, Gabriella
    CLINICAL AND EXPERIMENTAL MEDICINE, 2020, 20 (02) : 219 - 230
  • [24] Direct-acting antiviral treatment decreases serum undercarboxylated osteocalcin in male patients with chronic hepatitis C
    Ichikawa, Tatsuki
    Yamashima, Mio
    Yamamichi, Shinobu
    Koike, Makiko
    Nakano, Yusuke
    Honda, Tetsurou
    Yajima, Hiroyuki
    Miyazaki, Osamu
    Kuribayashi, Yasutaka
    Ikeda, Tomonari
    Okamura, Takuma
    Nakao, Kazuhiko
    BIOMEDICAL REPORTS, 2022, 17 (05)
  • [25] Prevalence and Outcome of Serum Autoantibodies in Chronic Hepatitis C Patients Undergoing Direct-Acting Antiviral Treatment
    Romano, Ciro
    Tortorella, Olga
    Dalla Mora, Liliana
    Di Stasio, Dario
    Sellitto, Ausilia
    Adinolfi, Luigi Elio
    Marrone, Aldo
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [26] Treatment with direct-acting antiviral agents is associated with increased platelet count in patients with chronic hepatitis C
    Hsu, Wei-Fan
    Peng, Cheng-Yuan
    Su, Wen-Pang
    Lai, Hsueh-Chou
    Lin, Chia-Hsin
    Chuang, Po-Heng
    Chen, Sheng-Hung
    Chen, Hung-Yao
    Wang, Hung-Wei
    Huang, Guan-Tarn
    ADVANCES IN DIGESTIVE MEDICINE, 2019, 6 (03) : 109 - 115
  • [27] Efficacy of direct-acting antiviral treatment for chronic hepatitis C: A single hospital experience
    Rena Kaneko
    Natsuko Nakazaki
    Risa Omori
    Yuichiro Yano
    Masazumi Ogawa
    Yuzuru Sato
    World Journal of Hepatology, 2018, (01) : 88 - 94
  • [28] Evaluation of Hepatitis C Patients in the Direct-Acting Antiviral Era
    Teriaky, Anouar
    Reau, Nancy
    CLINICS IN LIVER DISEASE, 2015, 19 (04) : 591 - +
  • [29] Direct-acting antiviral treatment failure in genotype 2 hepatitis C chronic infection
    Ridruejo, Ezequiel
    Pinero, Federico
    Mendizabal, Manuel
    Silva, Marcelo
    JOURNAL OF VIRAL HEPATITIS, 2021, 28 (02) : 446 - 447
  • [30] Association of Direct-Acting Antiviral Treatment With Mortality Among Medicare Beneficiaries With Hepatitis C
    Kalidindi, Yamini
    Jung, Jeah
    Feldman, Roger
    Riley, Thomas
    JAMA NETWORK OPEN, 2020, 3 (07)
12345